Aurora CO 肺动脉高压临床试验
9项针对 肺动脉高压的研究正在 Aurora及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
招募中2 期
- University of Colorado Denver, Aurora
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
招募中3 期
- University of Colorado Hospital, Aurora
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中观察性研究
- University of Colorado - Anschutz Medical Campus, Aurora
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
招募中4 期
- University of Colorado & Children's Hospital of Colorado (CU-CHC), Aurora
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
招募中2 期
- University of Colorado, Aurora
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
招募中2 期
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
招募中
- University of Colorado Anschutz Medical Campus, Aurora
Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease
招募中
- University of Colorado Anschutz Medical Campus, Aurora
Pulmonary Hypertension Association Registry
招募中观察性研究
- Children's Hospital Colorado, Aurora
- UC Health - Anschutz Medical Campus, Aurora
其他城市的 肺动脉高压试验
- Philadelphia, PA10 项研究
- Phoenix, AZ9 项研究
- Cincinnati, OH8 项研究
- New York City, NY8 项研究
- Indianapolis, IN8 项研究
- Boston, MA8 项研究
- Kansas City, KS8 项研究
- Rochester, MN7 项研究
- Charleston, SC7 项研究
- Houston, TX7 项研究
- Salt Lake City, UT7 项研究
- Bend, OR7 项研究
Aurora的其他研究
- 癌症(所有类型)35 项研究
- 结直肠癌32 项研究
- 非小细胞肺癌31 项研究
- 乳腺癌28 项研究
- 卵巢癌25 项研究
- 转移性癌症25 项研究
- 1型糖尿病23 项研究
- 肥胖症22 项研究
- 前列腺癌19 项研究
- 肺癌19 项研究
- 心力衰竭18 项研究
- 黑色素瘤18 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。